Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries worldwide. Fagron employs more than 2.000 employees, of which over 300 are dedicated pharmacists.
The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.
In 2016 Fagron attracted Waterland as its cornerstone investor in the context of a €220m capital increase. The purpose of this capital increase was to bring down the company’s financial leverage and lay the basis for a stable future growth trajectory.
For more information: www.fagron.com